Hand-Foot Syndrome Treatment Market Growth (2022-2030) | Industry Share, Size, Trends and Global Forecast Report

/EIN News/ -- Newark, New Castle, USA, March 09, 2023 (GLOBE NEWSWIRE) -- According to the deep-dive market assessment study by Growth Plus Reports, the global hand-foot syndrome treatment market is expected to register a revenue CAGR of 6.6% during the forecast period of 2022-2030

Market Drivers

As the global population is aging, the incidence of cancer is rising, thereby driving the demand for the global hand-foot syndrome treatment market. For instance, according to the WHO’s factsheet of October 2022, by 2030, one in every six people will be over 60, and by 2050. Healthcare professionals and patients are becoming more aware of hand-foot syndrome, which is driving the demand for treatments and resulting in the growth of the global hand-foot syndrome treatment market. Additionally, advances in drug development and delivery systems, such as transdermal drug delivery and nanotechnology, are providing new treatment options for hand-foot syndrome, which is boosting the growth of the global hand-foot syndrome treatment market. Moreover, companies across the globe are involved in partnerships, mergers & acquisitions which is also helping in the rise of the global hand-foot syndrome treatment market.

The global hand-foot syndrome treatment market is analyzed from three perspectives: Drug Class, Distribution Channel, and Region.

Get a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/hand-foot-syndrome-treatment-market/8299

Excerpts from ‘By Drug Class Segmentation’

Based on the drug class, the global hand-foot syndrome treatment market is segmented into analgesics, NSAID’s, antihistamines, and others.

Analgesics and NASID’s accounted for a major revenue share in 2021, attributed to the easy availability of analgesics as over-the-counter medicines. Analgesics are a class of drugs that are used to manage pain associated with hand-foot syndrome. They work by blocking pain signals to the brain. Commonly used analgesics for hand-foot syndrome include acetaminophen, opioids such as morphine or fentanyl, and tramadol. Analgesics can be used alone or in combination with other medications, such as NSAIDs or antihistamines, to manage hand-foot syndrome symptoms. The choice of analgesic will depend on the severity of the pain, the patient's medical history, and other individual factors. Opioids are typically reserved for more severe pain that is not adequately managed by other treatments. These factors contribute to the growth of the analgesics segment.

Excerpts from ‘By Distribution Channel Segmentation’

Based on the distribution channel, the global hand-foot syndrome treatment market is segmented into:

• Hospital
• Retail
• Online Pharmacy

Online Pharmacy is expected to be the fastest growing segment throughout the forecast period owing to the patient convenience and cost-effectiveness of the medicine. Online pharmacies may offer medications not available at traditional stores, including over-the-counter and prescription-only drugs. They may also provide discounts or other incentives, such as free shipping or loyalty programs, that can make treatment more affordable. Customers can now access a wide range of treatments and medications from the comfort of their own homes and have them delivered to their door. Furthermore, the availability of online consultations and prescription services has made it easier for patients to receive the care they need without having to leave the house. These factors are expected to boost the online pharmacy segment.

Excerpts from ‘By Region Segmentation’

Based on region, the global hand-foot syndrome treatment market has been segmented into:

• North America
• Europe
• Asia Pacific
• Rest of the World

North America dominated the global hand-foot syndrome treatment market with the largest revenue share in 2021, owing to expanding research & development efforts, rising healthcare expenditure, and the presence of key companies. Additionally, companies of this region are continuously involved in the research and development of new and novel drugs as well as treatment methods also resulting in the growth of the region. In January 2023, OnQuality Pharmaceuticals announced that it has received regulatory approval from both China and India for Part 2 of the NOVA-II Phase 2 clinical trial. This trial is focused on evaluating the effectiveness of OQL011, a topical ointment designed to manage Hand-Foot Skin Reaction (HFSR) in cancer patients who are undergoing anti-cancer treatment with vascular endothelial growth factor receptor (VEGFR) inhibitors. NOVA-II is a randomized, double-blinded, dose-ranging Phase 2 clinical trial that aims to determine the safety and efficacy of OQL011 as a topical ointment in treating VEGFRi-associated HFSR. The key objectives of the study include identifying the optimal dosage for Phase 3, evaluating the safety and efficacy of OQL011, and exploring the pharmacokinetics profile of OQL011 in HFSR patients.

Request for Customization – https://www.growthplusreports.com/inquiry/customization/hand-foot-syndrome-treatment-market/8299

Excerpts from ‘Competitive Landscape’

Some prominent players operating in the global hand-foot syndrome treatment market are:

• Sun Pharmaceutical Industries, Inc.
• Pfizer Inc.
• Eli Lilly and Company
• Merck & Co., Inc.
• Novartis International AG
• Teva Pharmaceutical Industries Ltd.
• Eisai Co. Ltd.
• GlaxoSmithKline plc
• Celgene Corporation
• Valeant Canada
• Oceanside Pharmaceuticals
• Baxter International, Inc.
• Biogen, Inc.

Hand-Foot Syndrome Treatment Market Scope

Report Attribute	Details
Growth Rate	CAGR of 6.6% from 2022 to 2030
Base year for estimation	2021
Forecast Period	2022-2030
Historical Year	2021
Segments Covered	Drug Class, Distribution Channel, and Region
Regional Scope	North America, Europe, Asia Pacific, and the Rest of the World (ROW)

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Forecast Years – 2022 to 2030
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trend (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2021) 
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL HAND-FOOT SYNDROME TREATMENT MARKET- ANALYSIS & FORECAST, BY TREATMENT TYPE
   1. Analgesics
   2. NSAIDs
   3. Antihistamines
   4. Multikinase Inhibitors
   5. Others
6. GLOBAL HAND-FOOT SYNDROME TREATMENT MARKET- ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL
   1. Hospitals Pharmacy
   2. Retail Pharmacy
   3. Online Pharmacy

TOC Continued..

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8299

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• 'Business Profile' of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at - https://www.growthplusreports.com/report-store

Browse related reports:

Radioligand Therapy (RLT) Market by Drug Class (Anti-androgen, Therapeutic Radiopharmaceuticals), Indication (Prostate Cancer, Neuroendocrine Tumors) – Global Outlook & Forecast 2022-2030

Pharmaceutical Filtration Market by Product, (Membrane Filters, Prefilters & Depth Media, Single-Use Systems), Technique (Microfiltration, Ultrafiltration, Crossflow Filtration) – Global Outlook & Forecast 2022-2030

Immunohematology Market by Product Type (Analyzers, Reagents & Consumables), Technology (Biochips, Gel Cards, Microplates, Polymerase Chain Reaction), End User (Blood Banks, Hospitals) – Global Outlook & Forecast 2022

Digital Temperature Monitoring Devices Market by Product (Tabletop, Handheld), Type (Contact-Based, Non-Contact-Based), End-user (Hospitals, Clinics) – Global Outlook & Forecast 2022-2030

Cast Removal Devices Market by Saw Type (Electric Cast Saw, Pneumatic-powered Cast Saw), Application (Plaster of Paris Cast Removal, Fiberglass Casting Tape Removal), End-user (Hospitals, Orthopedic Clinics) – Global Outlook & Forecast 2022-2030

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

Manan Sethi
                    Director, Market Insights
                    Email: sales@growthplusreports.com
                    256 Chapman Road
                    STE 105-4, Newark,
                    New Castle - 19702, USA
                    Phone no: +1 888 550 5009
                    Web: https://www.growthplusreports.com/